Biktarvy

Biktarvy is a combination medication used in the treatment of HIV-1 infection. It contains emtricitabine, tenofovir alafenamide, and bictegravir, offering a convenient once-daily oral option for managing HIV.

Biktarvy is primarily used for the treatment of HIV-1 infection in adults and children weighing at least 25 kg. This medication is designed to help control HIV, reducing the amount of virus in the body and improving immune function. It is often prescribed as part of a comprehensive treatment plan that includes other medications and lifestyle changes.

Common effects of Biktarvy may include nausea, diarrhea, and headache. Some individuals may also experience fatigue or changes in liver function. These effects can vary in severity and duration, and not everyone will experience them. It is important to discuss any persistent or concerning symptoms with a healthcare provider.

Biktarvy should be used with caution in individuals with a history of liver disease or kidney problems. Regular monitoring of liver function and kidney health is recommended. It is also important to inform healthcare providers about all other medications being taken to avoid potential interactions. Pregnant women or those planning to become pregnant should consult a healthcare provider before starting Biktarvy.

Biktarvy can interact with a variety of medications, including those metabolized by the liver's cytochrome P450 system. This includes certain anticonvulsants, antifungals, and antibiotics. It is also important to avoid taking Biktarvy with other HIV medications unless specifically directed by a healthcare provider. Alcohol consumption should be moderated, as it may exacerbate some side effects.